Health literacy is experiencing new challenges, and Medical Affairs is uniquely positioned to lead and partner with others in this space to ensure coordination, credibility and impact.
This MAPS Executive Consortium article explores ways in which Medical Affairs can help industry adapt its practices to deal with emerging issues in the transition to personalized medicine.
Download the new Dimensions White Paper to discover the current and emerging research trends in Pharma.
The MAPS Executive Consortium details how Medical Affairs will drive the evolution of industry to match the needs of a changing society.
The combined impact of treatment complexity and data availability highlights the value of Medical Affairs departments that have the capability to make clinical sense of new disruptive drugs, devices, real-time monitoring and diagnostics. Here, the MAPS Executive Consortium describes how.
Thank you MAPS Partner Circle members for sharing use cases that bring to life MAPS’ Vision for Generative Artificial Intelligence in Medical Affairs.
This article summarizes CRA’s roundtable discussion with Medical Affairs leaders in Lisbon, which focused on transitioning Medical Affairs to a function that is co-leading strategically the clinical development and commercialization efforts.
In this Within3 White Paper, learn how your team can work toward operational excellence for Medical Affairs, despite ever-shifting roles.
How can the Medical Affairs function overcome critical pain points with digital and AI tools?
With the advent of the digital age, Share of Voice has come to mean more than just numbers. Learn how to accurately measure Share of Voice in a digital age.